Comparative safety evaluation of silica-based particles

Toxicology in Vitro

Volumn 30, Issue 1, 2015, Pages 355-363

  Kettiger, Helene ^a   Sen Karaman, Didem ^b   Schiesser, Laura ^a   Rosenholm, Jessica M ^b   Huwyler, Jörg ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

Cell viability; Hemolysis; Oxidative stress; Silica nanoparticles

Indexed keywords

MESOPOROUS SILICA NANOPARTICLE; SILICA NANOPARTICLE; NANOPARTICLE; SILICON DIOXIDE;

ANIMAL CELL; ARTICLE; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; ERYTHROCYTE; HEMOLYSIS; HYDRODYNAMICS; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PHAGOCYTOSIS; PHYSICAL CHEMISTRY; POROSITY; RISK ASSESSMENT; SHEEP; SURFACE AREA; SURFACE CHARGE; SURFACE PROPERTY; SYNTHESIS; CELL SURVIVAL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HEP-G2 CELL LINE; HUMAN;

CELL SURVIVAL; DRUG DELIVERY SYSTEMS; HEMOLYSIS; HEP G2 CELLS; HUMANS; NANOPARTICLES; OXIDATIVE STRESS; PARTICLE SIZE; SILICON DIOXIDE;

EID: 84958524641     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2015.09.030     Document Type: Article

References (43)

1. Ahmad J., Ahamed M., Akhtar M.J., Alrokayan S.A., Siddiqui M.A., Musarrat J., Al-Khedhairy A.A. Apoptosis induction by silica nanoparticles mediated through reactive oxygen species in human liver cell line HepG2. Toxicol. Appl. Pharmacol. 2012, 259:160-168. 10.1016/j.taap.2011.12.020.
2. Bailey M.M., Berkland C.J. Nanoparticle formulations in pulmonary drug delivery. Med. Res. Rev. 2009, 29:196-212. 10.1002/med.20140.
3. Barandeh F., Nguyen P.-L., Kumar R., Iacobucci G.J., Kuznicki M.L., Kosterman A., Bergey E.J., Prasad P.N., Gunawardena S. Organically modified silica nanoparticles are biocompatible and can be targeted to neurons in vivo. PLoS ONE 2012, 7. 10.1371/journal.pone.0029424.
4. Blaise C., Gagné F., Férard J.F., Eullaffroy P. Ecotoxicity of selected nano-materials to aquatic organisms. Environ. Toxicol. 2008, 23:591-598. 10.1002/tox.20402.
5. Byrne J.D., Baugh J.A. The significance of nanoparticles in particle-induced pulmonary fibrosis. McGill J. Med. 2008, 11:43-50.
6. Casey A., Herzog E., Lyng F.M., Byrne H.J., Chambers G., Davoren M. Single walled carbon nanotubes induce indirect cytotoxicity by medium depletion in A549 lung cells. Toxicol. Lett. 2008, 179:78-84. 10.1016/j.toxlet.2008.04.006.
7. Chen K., Zhang J., Gu H. Dissolution from inside: a unique degradation behaviour of core-shell magnetic mesoporous silica nanoparticles and the effect of polyethyleneimine coating. J. Mater. Chem. 2012, 22:22005-22012. 10.1039/C2JM34364A.
8. Coradin T., Eglin D., Livage J. The silicomolybdic acid spectrophotometric method and its application to silicate/biopolymer interaction studies. J. Spectrosc. 2004, 18:567-576. 10.1155/2004/356207.
9. dos Santos T., Varela J., Lynch I., Salvati A., Dawson K.A. Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. Small 2011, 7:3341-3349. 10.1002/smll.201101076.
10. Ensign L.M., Cone R., Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv. Drug Deliv. Rev. 2012, 64:557-570. 10.1016/j.addr.2011.12.009.
11. Escobar-Chavez J., Diaz-Torres R., Rodriguez-Cruz I.M., Dominguez-Delgado Sampere-Morales, Angeles-Anguiano Melgoza-Contreras Nanocarriers for transdermal drug delivery. Res. Rep. Transdermal Drug Deliv. 2012, 3. 10.2147/RRTD.S32621.
12. Fisichella M., Dabboue H., Bhattacharyya S., Saboungi M.-L., Salvetat J.-P., Hevor T., Guerin M. Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes. Toxicol. Vitro Int. J. Publ. Assoc. BIBRA 2009, 23:697-703. 10.1016/j.tiv.2009.02.007.
13. Ge C., Du J., Zhao L., Wang L., Liu Y., Li D., Yang Y., Zhou R., Zhao Y., Chai Z., Chen C. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc. Natl. Acad. Sci. 2011, 108:16968-16973. 10.1073/pnas.1105270108.
14. Gu J., Fan W., Shimojima A., Okubo T. Organic-inorganic mesoporous nanocarriers integrated with biogenic ligands. Small 2007, 3:1740-1744. 10.1002/smll.200700311.
15. Halliwell B., Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br. J. Pharmacol. 2004, 142:231-255. 10.1038/sj.bjp.0705776.
16. Han L., Wei H., Tu B., Zhao D. A facile one-pot synthesis of uniform core-shell silver nanoparticle@mesoporous silica nanospheres. Chem. Commun. 2011, 47:8536-8538. 10.1039/C1CC12718G.
17. He Q., Zhang Z., Gao Y., Shi J., Li Y. Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles. Small Weinh Bergstr. Ger. 2009, 5:2722-2729. 10.1002/smll.200900923.
18. Karaman D.S., Desai D., Senthilkumar R., Johansson E.M., Råtts N., Odén M., Eriksson J.E., Sahlgren C., Toivola D.M., Rosenholm J.M. Shape engineering vs organic modification of inorganic nanoparticles as a tool for enhancing cellular internalization. Nanoscale Res. Lett. 2012, 7:358. 10.1186/1556-276X-7-358.
19. Kettiger H., Schipanski A., Wick P., Huwyler J. Engineered nanomaterial uptake and tissue distribution: from cell to organism. Int. J. Nanomedicine 2013, 8:3255-3269. 10.2147/IJN.S49770.
20. Kim S., Jang J., Kim H., Choi H., Lee K., Choi I.-H. The effects of silica nanoparticles in macrophage cells. Immune Netw. 2012, 12:296-300. 10.4110/in.2012.12.6.296.
21. Kroll A., Dierker C., Rommel C., Hahn D., Wohlleben W., Schulze-Isfort C., Göbbert C., Voetz M., Hardinghaus F., Schnekenburger J. Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays. Part. Fibre Toxicol. 2011, 8:9. 10.1186/1743-8977-8-9.
22. Kroll A., Pillukat M.H., Hahn D., Schnekenburger J. Interference of engineered nanoparticles with in vitro toxicity assays. Arch. Toxicol. 2012, 86:1123-1136. 10.1007/s00204-012-0837-z.
23. Krug H.F., Wick P. Nanotoxicology: an interdisciplinary challenge. Angew. Chem. Int. Ed. 2011, 50:1260-1278. 10.1002/anie.201001037.
24. Li Y., Sun L., Jin M., Du Z., Liu X., Guo C., Li Y., Huang P., Sun Z. Size-dependent cytotoxicity of amorphous silica nanoparticles in human hepatoma HepG2 cells. Toxicol. Vitro Int. J. Publ. Assoc. BIBRA 2011, 25:1343-1352. 10.1016/j.tiv.2011.05.003.
25. Lin Y.-S., Haynes C.L. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J. Am. Chem. Soc. 2010, 132:4834-4842. 10.1021/ja910846q.
26. Meißner T., Potthoff A., Richter V. Suspension characterization as important key for toxicological investigations. J. Phys. Conf. Ser. 2009, 170:012012. 10.1088/1742-6596/170/1/012012.
27. Napierska D., Thomassen L.C.J., Rabolli V., Lison D., Gonzalez L., Kirsch-Volders M., Martens J.A., Hoet P.H. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small Weinh. Bergstr. Ger. 2009, 5:846-853. 10.1002/smll.200800461.
28. Napierska D., Rabolli V., Thomassen L.C.J., Dinsdale D., Princen C., Gonzalez L., Poels K.L.C., Kirsch-Volders M., Lison D., Martens J.A., Hoet P.H. Oxidative stress induced by pure and iron-doped amorphous silica nanoparticles in subtoxic conditions. Chem. Res. Toxicol. 2012, 25:828-837. 10.1021/tx200361v.
29. Ow H., Larson D.R., Srivastava M., Baird B.A., Webb W.W., Wiesner U. Bright and stable core-shell fluorescent silica nanoparticles. Nano Lett. 2004, 5:113-117. 10.1021/nl0482478.
30. Rosenholm J.M., Peuhu E., Eriksson J.E., Sahlgren C., Lindén M. Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems. Nano Lett. 2009, 9:3308-3311. 10.1021/nl901589y.
31. Sayes C.M., Reed K.L., Warheit D.B. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol. Sci. 2007, 97:163-180. 10.1093/toxsci/kfm018.
32. Seeland S., Toeroek M., Kettiger H., Treiber A., Hafner M., Huwyler J. A cell-based, multiparametric sensor approach characterises drug-induced cytotoxicity in human liver HepG2 cells. Toxicol. In Vitro 2013, 27:1109-1120. 10.1016/j.tiv.2013.02.001.
33. Slowing I.I., Wu C.-W., Vivero-Escoto J.L., Lin V.S.-Y. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 2009, 5:57-62. 10.1002/smll.200800926.
34. Sohaebuddin S.K., Thevenot P.T., Baker D., Eaton J.W., Tang L. Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part. Fibre Toxicol. 2010, 7:22. 10.1186/1743-8977-7-22.
35. Stoeber W., Fink A., Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. J. Colloid Interface Sci. 1968, 26:62-69. 10.1016/0021-9797(68)90272-5.
36. Tao Z., Toms B.B., Goodisman J., Asefa T. Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials. Chem. Res. Toxicol. 2009, 22:1869-1880. 10.1021/tx900276u.
37. Vranic S., Boggetto N., Contremoulins V., Mornet S., Reinhardt N., Marano F., Baeza-Squiban A., Boland S. Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometry. Part. Fibre Toxicol. 2013, 10:2. 10.1186/1743-8977-10-2.
38. Wicki A., Witzigmann D., Balasubramanian V., Huwyler J. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J. Control. Release 2015, 200:138-157. 10.1016/j.jconrel.2014.12.030.
39. Wu S.-H., Hung Y., Mou C.-Y. Mesoporous silica nanoparticles as nanocarriers. Chem. Commun. 2011, 47:9972. 10.1039/c1cc11760b.
40. Yu T., Malugin A., Ghandehari H. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 2011, 5:5717-5728. 10.1021/nn2013904.
41. Zhang H., Xia T., Meng H., Xue M., George S., Ji Z., Wang X., Liu R., Wang M., France B., Rallo R., Damoiseaux R., Cohen Y., Bradley K.A., Zink J.I., Nel A.E. Differential expression of Syndecan-1 mediates cationic nanoparticle toxicity in undifferentiated versus differentiated normal human bronchial epithelial cells. ACS Nano 2011, 5:2756-2769. 10.1021/nn200328m.
42. Zhang H., Dunphy D.R., Jiang X., Meng H., Sun B., Tarn D., Xue M., Wang X., Lin S., Ji Z., Li R., Garcia F.L., Yang J., Kirk M.L., Xia T., Zink J.I., Nel A., Brinker C.J. Processing pathway dependence of amorphous silica nanoparticle toxicity: colloidal vs pyrolytic. J. Am. Chem. Soc. 2012, 134:15790-15804. 10.1021/ja304907c.
43. Zhuravlev L.T. The surface chemistry of amorphous silica. Zhuravlev model. Colloids Surf. A Physicochem. Eng. Asp. 2000, 173:1-38. 10.1016/S0927-7757(00)00556-2.